Tripartite motif-containing 29 as a novel biomarker in non-small cell lung cancer
Authors:
Open Access
- 19 August 2015
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 10 (4) , 2283-2288
Abstract
Tripartite motif-containing 29 (TRIM29) is a member of the tripartite motif (TRIM) protein family. TRIM29 has been reported to be deregulated in a number of cancer types, suggesting the oncogenic function of TRIM29. However, its clinical significance in non-small cell lung cancer (NSCLC) has not been fully elucidated. In the present study, the TRIM29 expression status was investigated by immunohistochemical analysis in paraffin-embedded specimens obtained from 320 patients with surgically resected NSCLC, treated between 2000 and 2007. High TRIM29 expression was significantly associated with smoking (P=0.012), T stage (P=0.015) and M stage (P=0.003). Furthermore, elevated TRIM29 expression level was correlated with reduced overall (OS) and disease-free survival. In addition, high TRIM29 expression was an independent prognostic factor for OS [P=0.003, hazard ratio (HR)=2.102, 95% confidence interval (CI), 1.069–3.193]. In conclusion, these results suggest that TRIM29 may be a useful prognostic marker in NSCLC patients and a potential molecular target for NSCLC treatment.Keywords
This publication has 22 references indexed in Scilit:
- Aggressive Treatment of Primary Tumor in Patients With Non–Small-Cell Lung Cancer and Exclusively Brain MetastasesClinical Lung Cancer, 2013
- TRIM29 Functions as a Tumor Suppressor in Nontumorigenic Breast Cells and Invasive ER+ Breast CancerThe American Journal of Pathology, 2012
- Clinical significance of CD151 overexpression in subtypes of invasive breast cancerBritish Journal of Cancer, 2012
- TRIM family: Pleiotropy and diversification through homomultimer and heteromultimer formationIUBMB Life, 2011
- TRIM29 negatively regulates p53 via inhibition of Tip60Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Prognostic Significance of CD151 Expression in Esophageal Squamous Cell Carcinoma with Aggressive Cell Proliferation and InvasivenessAnnals of Surgical Oncology, 2010
- The ATDC (TRIM29) Protein Binds p53 and Antagonizes p53-Mediated FunctionsMolecular and Cellular Biology, 2010
- Tripartite Motif-Containing 29 (TRIM29) Is a Novel Marker for Lymph Node Metastasis in Gastric CancerAnnals of Surgical Oncology, 2007
- Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21Cancer Gene Therapy, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001